关注
Jake Pry
Jake Pry
其他姓名Jake M. Pry, Jesse Pry
UC Davis; Centre for Infectious Disease Research in Zambia (CIDRZ)
在 ucdavis.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection—California, February–December 2021
KL Andrejko, JM Pry, JF Myers, N Fukui, JL DeGuzman, J Openshaw, ...
MMWR. Morbidity and Mortality Weekly Report 71, 2022
203*2022
Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting
JE Lawn, EO Ohuma, E Bradley, LS Idueta, E Hazel, YB Okwaraji, ...
The Lancet 401 (10389), 1707-1719, 2023
1182023
Human-centered design lessons for implementation science: improving the implementation of a patient-centered care intervention
LK Beres, S Simbeza, CB Holmes, C Mwamba, N Mukamba, A Sharma, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 82, S230-S243, 2019
692019
Prevention of coronavirus disease 2019 (COVID-19) by mRNA-based vaccines within the general population of California
KL Andrejko, J Pry, JF Myers, NP Jewell, J Openshaw, J Watt, S Jain, ...
Clinical Infectious Diseases 74 (8), 1382-1389, 2022
66*2022
Predictors of severe acute respiratory syndrome coronavirus 2 infection following high-risk exposure
KL Andrejko, J Pry, JF Myers, J Openshaw, J Watt, N Birkett, ...
Clinical Infectious Diseases 75 (1), e276-e288, 2022
312022
Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression …
A Mody, I Sikazwe, AS Namwase, MW Mwanza, T Savory, A Mwila, ...
The Lancet HIV 8 (12), e755-e765, 2021
292021
Cervical cancer screening outcomes in Zambia, 2010–19: a cohort study
JM Pry, A Manasyan, S Kapambwe, K Taghavi, M Duran-Frigola, ...
The Lancet Global Health 9 (6), e832-e840, 2021
282021
Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia
A Mody, I Sikazwe, NL Czaicki, M Wa Mwanza, T Savory, K Sikombe, ...
PLoS medicine 15 (6), e1002574, 2018
232018
Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia
MJ Vinikoor, E Sinkala, A Kanunga, M Muchimba, A Zanolini, M Saag, ...
PLoS One 15 (1), e0227041, 2020
212020
Severe acute respiratory syndrome coronavirus 2 and respiratory virus sentinel surveillance, California, USA, May 10, 2020–June 12, 2021
GLS Cooksey, C Morales, L Linde, S Schildhauer, H Guevara, E Chan, ...
Emerging Infectious Diseases 28 (1), 9, 2022
202022
Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trial
M Roy, C Bolton-Moore, I Sikazwe, M Mukumbwa-Mwenechanya, ...
PLoS medicine 17 (7), e1003116, 2020
19*2020
Patterns and predictors of incident return to HIV care among traced, disengaged patients in Zambia: analysis of a prospective cohort
LK Beres, S Schwartz, S Simbeza, J McGready, I Eshun-Wilson, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 86 (3), 313-322, 2021
182021
Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before–after cohort study using mixed effects regression
JM Pry, K Sikombe, A Mody, S Iyer, J Mutale, N Vlahakis, T Savory, ...
BMJ global health 7 (1), e007312, 2022
172022
Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost …
AD Kerkhoff, K Sikombe, I Eshun-Wilson, I Sikazwe, DV Glidden, JM Pry, ...
PLoS medicine 17 (5), e1003107, 2020
172020
Patient‐reported reasons for declining same‐day antiretroviral therapy initiation in routine HIV care settings in Lusaka, Zambia: results from a mixed‐effects regression analysis
J Pry, J Chipungu, HJ Smith, CB Moore, J Mutale, M Duran‐Frigola, ...
Journal of the International AIDS Society 23 (7), e25560, 2020
162020
A pilot case-control study using a one health approach to evaluate behavioral, environmental, and occupational risk factors for chronic kidney disease of unknown etiology in …
J M Pry, W Jackson, R Rupasinghe, G Lishanthe, Z Badurdeen, ...
One health outlook 3, 1-12, 2021
15*2021
Longitudinal care cascade outcomes among people eligible for antiretroviral therapy who are newly linking to care in Zambia: a multistate analysis
A Mody, DV Glidden, I Eshun-Wilson, K Sikombe, S Simbeza, N Mukamba, ...
Clinical Infectious Diseases 71 (10), e561-e570, 2020
152020
Understanding patient transfers across multiple clinics in Zambia among HIV infected adults
K Sikombe, A Mody, J Kadota, JJ Pry, S Simbeza, I Eshun-Wilson, ...
PLoS One 15 (11), e0241477, 2020
142020
Profiles of HIV care disruptions among adult patients lost to follow-up in Zambia: a latent class analysis
A Mody, K Sikombe, LK Beres, S Simbeza, N Mukamba, I Eshun-Wilson, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 86 (1), 62-72, 2021
132021
Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: a registry-linkage study
KL Andrejko, JF Myers, N Fukui, L Nelson, R Zhao, J Openshaw, JP Watt, ...
Vaccine 41 (10), 1649-1656, 2023
122023
系统目前无法执行此操作,请稍后再试。
文章 1–20